Name: Acrivon Therapeutics, Inc. (ACRV) Balance Sheet
Creator: FinSpry

Acrivon Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Acrivon Therapeutics, Inc. (ACRV) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	39.82	127.46	127.75	99.60	1.58
Short-Term Investments	139.66	91.44	98.23	0.00	0.00
Cash & Short-Term Investments	179.48	127.46	127.75	99.60	1.58
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.15	2.23	4.34	0.81	0.14
Total Current Assets	181.63	129.69	132.10	100.41	1.72
Non-Current Assets
Property, Plant & Equipment (Net)	8.03	7.91	6.86	5.79	0.06
Long-Term Investments	5.09	0.00	41.88	0.00	0.00
Other Non-Current Assets	1.35	0.67	0.39	0.39	0.41
Total Non-Current Assets	14.96	8.57	49.13	6.18	0.00
Total Assets	196.59	138.27	181.23	106.59	2.19
Current Liabilities
Accounts Payable	0.76	12.43	5.79	0.96	0.14
Short-Term Debt	1.06	0.00	0.00	0.00	0.00
Accrued Liabilities	15.40	7.38	2.16	0.55	0.42
Deferred Revenue	0.00	0.00	0.07	0.07	0.00
Other Current Liabilities	15.40	0.00	0.67	0.00	0.00
Total Current Liabilities	17.21	13.30	6.52	2.91	0.61
Non-Current Liabilities
Long-Term Debt	2.59	3.77	4.24	4.96	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	2.59	3.77	4.24	127.48	0.00
Total Liabilities	19.80	17.07	10.75	130.40	0.61
Stockholders' Equity
Common Stock	0.03	0.02	0.02	0.00	0.00
Retained Earnings	-196.98	-116.50	-56.13	-24.87	-8.62
Accumulated Other Comprehensive Income	0.45	-0.08	-0.10	0.00	0.00
Additional Paid-in Capital	373.28	237.68	226.58	1.05	0.00
Shares Outstanding	31.23	22.52	21.92	18.81	0.00
Total Stockholders' Equity	176.79	121.20	170.48	-23.81	1.57
Total Liabilities & Equity	196.59	138.27	181.23	106.59	0.00